Illumina, Inc.
Illumina Appoints Dr. Daniel Skovronsky to Board of Directors
Summary
Illumina, Inc. announced on June 16, 2026, the appointment of Daniel M. Skovronsky, M.D., Ph.D., to its Board of Directors, effective immediately. Dr. Skovronsky, currently the Chief Scientific and Product Officer of Eli Lilly and Company, brings extensive experience in drug discovery, clinical development, and translational medicine, which are directly relevant to Illumina's work in genomics and multiomics platforms. He will stand for election at the Company's 2027 annual meeting of stockholders to serve for a one-year term. Dr. Skovronsky qualifies as an independent director under the applicable rules of The Nasdaq Stock Market and the Securities and Exchange Commission.
Profitelligence Alerts
Get alerts for ILMN
Be first to know when Illumina, Inc. files with the SEC.
Filing Categories
Advertisement
About Illumina, Inc.
Illumina, Inc. operates as a global leader in the life sciences industry, focusing on the development and manufacturing of integrated systems for the analysis of genetic variation and function. Primarily, Illumina’s products and services are pivotal in advancing genomic research, enabling scientists to explore DNA sequencing and genetic mapping with high precision and efficiency. The company’s solutions are extensively utilized in fields such as oncology, reproductive health, and genetic disease diagnostics. Known for its cutting-edge sequencing tools, Illumina plays a crucial role in driving innovation in personalized medicine, helping to tailor medical treatments to individual genetic profiles. Headquartered in San Diego, California, Illumina contributes significantly to the genomics sector’s expansion, supporting initiatives in health and medicine, agrigenomics, and microbiology. By providing critical tools for genetic analysis, Illumina aids researchers and clinical laboratories worldwide, influencing how healthcare is approached and offering insights into complex biological systems.
Official SEC Documents
Advertisement